Genome-wide CNV analysis replicates the association between GSTM1 deletion and bladder cancer: a support for using continuous measurement from SNP-array data
Authors:
- Gaëlle MarenneGMGaëlle Marenne
- Francisco X RealFRFrancisco X Real
- Nathaniel RothmanNRNathaniel Rothman
- Benjamin Rodríguez-SantiagoBRBenjamin Rodríguez-Santiago
- Luis Pérez-JuradoLPLuis Pérez-Jurado
- Manolis KogevinasMKManolis Kogevinas
- Montse García-ClosasMGMontse García-Closas
- Debra T SilvermanDSDebra T Silverman
- Stephen J ChanockSCStephen J Chanock
- Emmanuelle GéninEmmanuelle Génin
- Núria MalatsNMNúria Malats
Open Access
- 20 July 2012
- journal article
- research article
- Published by Springer Nature in BMC Genomics
- Vol. 13 (1) , 1-7
Abstract
Background: Structural variations such as copy number variants (CNV) influence the expression of different phenotypic traits. Algorithms to identify CNVs through SNP-array platforms are available. The ability to evaluate well-characterized CNVs such as GSTM1 (1p13.3) deletion provides an important opportunity to assess their performance. Results: 773 cases and 759 controls from the SBC/EPICURO Study were genotyped in the GSTM1 region using TaqMan, Multiplex Ligation-dependent Probe Amplification (MLPA), and Illumina Infinium 1 M SNP-array platforms. CNV callings provided by TaqMan and MLPA were highly concordant and replicated the association between GSTM1 and bladder cancer. This was not the case when CNVs were called using Illumina 1 M data through available algorithms since no deletion was detected across the study samples. In contrast, when the Log R Ratio (LRR) was used as a continuous measure for the 5 probes contained in this locus, we were able to detect their association with bladder cancer using simple regression models or more sophisticated methods such as the ones implemented in the CNVtools package. Conclusions: This study highlights an important limitation in the CNV calling from SNP-array data in regions of common aberrations and suggests that there may be added advantage for using LRR as a continuous measure in association tests rather than relying on calling algorithms.Keywords
This publication has 26 references indexed in Scilit:
- Assessment of copy number variation using the Illumina Infinium 1M SNP-array: a comparison of methodological approaches in the Spanish Bladder Cancer/EPICURO studyHuman Mutation, 2010
- PennCNV: An integrated hidden Markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping dataGenome Research, 2007
- Copy-number variation and association studies of human diseaseNature Genetics, 2007
- QuantiSNP: an Objective Bayes Hidden-Markov Model to detect and accurately map copy number variation using SNP genotyping dataNucleic Acids Research, 2007
- Relative Impact of Nucleotide and Copy Number Variation on Gene Expression PhenotypesScience, 2007
- NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analysesThe Lancet, 2005
- Glutathione S-transferase genotypes and cancer riskCancer Letters, 2005
- Detection of large-scale variation in the human genomeNature Genetics, 2004
- Glutathione S-Transferase Polymorphisms and Colorectal Cancer: A HuGE ReviewAmerican Journal of Epidemiology, 2000
- Review of studies of selected metabolic polymorphisms and cancer.1999